Neurocrine Biosciences, Inc. (NBIX)
143.18
+2.47
(+1.76%)
USD |
NASDAQ |
Oct 02, 16:00
144.60
+1.42
(+0.99%)
After-Hours: 20:00
Neurocrine Biosciences Profit Margin (Quarterly) : 15.06% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 15.06% |
| March 31, 2026 | 24.30% |
| December 31, 2025 | 19.08% |
| September 30, 2025 | 26.36% |
| June 30, 2025 | 15.64% |
| March 31, 2025 | 1.38% |
| December 31, 2024 | 16.42% |
| September 30, 2024 | 20.86% |
| June 30, 2024 | 11.01% |
| March 31, 2024 | 8.42% |
| December 31, 2023 | 28.67% |
| September 30, 2023 | 16.66% |
| June 30, 2023 | 21.10% |
| March 31, 2023 | -18.22% |
| December 31, 2022 | 21.60% |
| September 30, 2022 | 17.66% |
| June 30, 2022 | -4.47% |
| March 31, 2022 | 4.48% |
| December 31, 2021 | -2.34% |
| September 30, 2021 | 7.60% |
| June 30, 2021 | 14.64% |
| March 31, 2021 | 13.57% |
| December 31, 2020 | |
| September 30, 2020 | -22.28% |
| June 30, 2020 | 26.32% |
| Date | Value |
|---|---|
| March 31, 2020 | 15.77% |
| December 31, 2019 | 13.93% |
| September 30, 2019 | 24.22% |
| June 30, 2019 | 27.96% |
| March 31, 2019 | -73.78% |
| December 31, 2018 | 13.75% |
| September 30, 2018 | 33.45% |
| June 30, 2018 | -6.10% |
| March 31, 2018 | -58.83% |
| December 31, 2017 | 7.29% |
| September 30, 2017 | -18.31% |
| June 30, 2017 | -946.9% |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | -128.4% |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | -6.03% |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Amarin Corp. Plc | -18.12% |
| Liquidia Corp. | 43.52% |
| BioCryst Pharmaceuticals, Inc. | 35.92% |
| Halozyme Therapeutics, Inc. | 47.80% |
| Iovance Biotherapeutics, Inc. | -47.64% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 21.98% |
| Return on Assets | 15.22% |
| Return on Invested Capital | 19.28% |
| Gross Profit Margin (Quarterly) | 95.87% |
| Operating Margin (Quarterly) | 15.95% |
| Return on Net Operating Assets | 33.95% |